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Abstract
Objective: Permanent hypoparathyroidism is an uncommon disease resulting most 
frequently from neck surgery. It has been associated with visceral calcifications but 
few studies have specifically this in patients with post-surgical hypoparathyroidism. 
The aim of the present study was to assess the prevalence of basal ganglia and carotid 
artery calcifications in patients with long-term post-thyroidectomy hypoparathyroidism 
compared with a control population.
Design: Case–control study.
Methods: A cross-sectional review comparing 29 consecutive patients with permanent 
postoperative hypoparathyroidism followed-up in a tertiary reference unit for Endocrine 
Surgery with a contemporary control group of 501 patients who had an emergency 
brain CT scan. Clinical variables and prevalence of basal ganglia and carotid artery 
calcifications were recorded.
Results: From a cohort of 46 patients diagnosed with permanent hypoparathyroidism, 
29 were included in the study. The mean duration of disease was 9.2 ± 7 years. Age, 
diabetes, hypertension, smoking and dyslipidemia were similarly distributed in case 
and control groups. The prevalence of carotid artery and basal ganglia calcifications 
was 4 and 20 times more frequent in patients with permanent hypoparathyroidism, 
respectively. After propensity score matching of the 28 the female patients, 68 controls 
were matched for age and presence of cardiovascular factors. Cases showed a four-
fold prevalence of basal ganglia calcifications, whereas that of carotid calcifications was 
similar between cases and controls.
Conclusion: A high prevalence of basal ganglia calcifications was observed in patients with 
post-surgical permanent hypoparathyroidism. It remains unclear whether carotid artery 
calcification may also be increased.
Introduction
Permanent hypoparathyroidism is a rare disorder 
characterized by low or inappropriately normal 
levels of parathyroid hormone leading to low 
calcium and increased phosphate serum levels (1). 
Immune-mediated destruction of the parathyroid glands, 
idiopathic and inherited hypoparathyroidism such as 
DiGeorge syndrome and activating mutations in the 
extracellular calcium-sensing receptor or mutations in 
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the pre-proPTH, are uncommon causes of permanent 
hypoparathyroidism (1).
The commonest etiology of permanent parathyroid 
failure (up to three quarters of the cases (2, 3)) is 
postoperative hypoparathyroidism mostly due to 
intraoperative injury to the parathyroid glands, 
autotransplantation or inadvertent parathyroidectomy 
(4), all leading to a reduction of the functional parathyroid 
parenchyma.
As total thyroidectomy has been gaining popularity 
during the last three decades for the management of a 
variety of thyroid disorders, postoperative parathyroid 
failure has emerged as the most common early adverse 
effect of thyroidectomy, eventually progressing to 
permanent hypoparathyroidism, a complication requiring 
life-long medical supervision and treatment.
The estimated prevalence of permanent 
hypoparathyroidism after total thyroidectomy varies 
between 0 and 3% as reported in literature reviews (5) 
and 6–12% according to more realistic national registries 
and multicenter studies (6). Some studies dealing with 
current management policies, quality of life and the risk 
of complications have been published in recent years and 
reviewed in the European Guidelines (7).
A Danish case–control study (8) assessing 668 
patients with post-surgical hypoparathyroidism showed 
that they had almost five-fold increase the rate of renal 
stones in comparison with the normal population. One 
year later, the same authors reported a significantly 
increased risk of hospitalization due to infections and 
depression/bipolar affective disorders (9). The PARADOX 
study also captured a significant impact of permanent 
hypoparathyroidism on the quality of life (10). Our group 
previously reported at least one clinical adverse event 
was observed in 56.3% of patients with post-surgical 
permanent hypoparathyroidism and a slight decrease 
of the punctuation in the SF-36 questionnaire for the 
perceived quality of life that was only significant for the 
emotional role (11).
Another well-known complication of long-term 
hypoparathyroidism with uncertain clinical significance is 
basal ganglia calcifications (BGC). Mitchell et al. (2) found 
the prevalence of BGC was 51.6%. Even a higher prevalence 
of 74% was found by Goswami et al. (12) in 145 patients 
with idiopathic hypoparathyroidism. These two authors 
suggested chronic hyperphosphatemia may contribute 
to basal ganglia calcifications in hypoparathyroidism. 
Patients with post-surgical hypoparathyroidism were 
few or not included in these studies. In a recent study 
analyzing a cohort of 1133 patients suspected of acute 
ischemic stroke, female gender, hypertension, diabetes, 
hyperlipidemia, smoking and previous stroke were 
associated with BGC; a low BMI and older age were 
identified as the most powerful predicting risk factors (13).
It has been reported that alteration in calcium, 
phosphate and parathyroid hormone homeostasis is a 
predisposing factor for vascular calcification and increases 
the risk of cardiovascular disease in patients with end-
stage renal disease (14, 15). This same relationship in 
patients with permanent hypoparathyroidism remains 
unexplored. Underberg et al., showed the cardiovascular 
risk was increased in non-surgical hypoparathyroidism 
but not in post-surgical hypoparathyroidism (8). The 
Rotterdam study (16) found current smoking, age, 
hypertension, hypercholesterolemia and diabetes were 
risk factors for calcifications in carotid, coronary and 
aortic arch branches.
No studies have specifically investigated the 
occurrence of visceral calcifications in patients with 
permanent hypoparathyroidism of surgical etiology. 
Thus, the aim of the present work was to investigate the 
prevalence of BGC and carotid calcification in patients 
with post-thyroidectomy hypoparathyroidism compared 
with that in the general population.
Methods
A case–control study was designed as a cross-sectional 
review comparing the prevalence of visceral calcifications. 
Cases were 46 consecutive patients (Fig. 1) with 
permanent postoperative hypoparathyroidism whose 
data was obtained from a single-center prospectively 
maintained clinical database. These patients had either 
total thyroidectomy (with or without lymph node 
dissection) or either for benign or malignant condition 
or thyroparathyroidectomy for concomitant primary 
hyperparathyroidism between 1984 and 2017. Patients 
with secondary hyperparathyroidism were excluded. 
All the procedures were performed by the same team 
of experienced endocrine surgeons at the Hospital 
Universitari del Mar in Barcelona, Spain, a referral center 
for Endocrine Surgery.
Patients diagnosed with permanent 
hypoparathyroidism were followed-up in our outpatient 
clinic every 6 months monitoring intact PTH (iPTH), serum 
calcium, 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, 
and kidney function (creatinine and estimated glomerular 
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filtration). Typically, patients received treatment with 
calcium salts (1.5–3.0 g of calcium/day) and vitamin D 
analogues: calcitriol (Rocaltrol®), 0.25–1.00 µg/day and/or 
calcifediol (Hidroferol®), 266 mg, one to three times/week. 
There was no formal criterion to use one or the other (11) 
but calcifediol was the preferred drug for patients with 
creatinine >1 mg/dL.
iPTH levels were determined using either an immune-
radiometric second generation assay using IRMA Total 
Intact assay (Scantibodies Laboratory Inc. Santee, CA, 
USA) or a solid-phase, two-site chemiluminescent 
enzyme-labeled assay IMMULITE 2000 Intact PTH assay 
(Siemens Healthcare Diagnostics Spain, Madrid, Spain); 
with a normal range of 13–65 pg/mL and a detection limit 
of 3 pg/mL. In addition to routine kidney ultrasound, 
bone mineral density scan (DXA), 24-h urine calcium test, 
some patients agreed to undergo CT-scan to assess BGC 
and carotid calcifications.
The control group consisted of patients (n = 501) 
who attended the Emergency Department for either head 
trauma, stroke or headache and had a cranial CT-scan 
between January and April 2018 (Fig. 1). Information on 
smoking, blood pressure and lipid-lowering medication 
use was obtained through the medical records and 
electronic prescription system.
The study was approved by Hospital del Mar Ethics 
Committee. Written informed consent was obtained from 
all the cases.
Sample size
The case-cohort consisted of 46 patients with permanent 
hypoparathyroidism diagnosed and followed at a single 
center. The relatively small sample size for this study 
reflects the low-rate of this complication in a specialized 
unit (about 4.5% of all total thyroidectomies).
The estimated prevalence of basal ganglia calcification 
in the general population lies somewhere between 2 and 
12.5% (17, 18). Large population studies have reflected 
a prevalence of carotid calcifications ranging between 2 
and 4% (19, 20). To obtain a minimum number of BGC 
and carotid calcifications, a control sample of 500 patients 
was selected.
Prevalence of basal ganglia and carotid artery 
calcifications was assessed with CT scan and supra-aortic 
ultrasound when available.
Definitions
Permanent hypoparathyroidism was defined as a 
subnormal iPTH concentration (<13 pg/mL) and need for 
calcium replacement with or without activated vitamin 
D metabolites for more than 1 year after surgery (6, 21). 
A few patients recovering after this time period were not 
included (22).
Regarding cardiovascular risk factors, the subjects were 
categorized as current, past and non-smokers. We defined 
hypertension, hypercholesterolemia and diabetes as the 
Figure 1
Patient flow diagram.
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use of blood pressure-lowering medication, lipid reducing 
medication or of anti-diabetic drugs, respectively. Height 
and weight were measured in cases, and the BMI was 
calculated (weight(kg)/height(m)2). We defined obesity as 
a BMI >30 kg/m2.
Carotid calcifications were defined as calcifications 
reported by radiologists in the brain CT scan and/or 
described in a supra-aortic Doppler ultrasound. BGC 
was defined according to findings on the brain CT-scan 
reviewed by a Neuroradiologist.
Statistical analysis
Comparison of proportions was investigated with the 
Chi-square or exact Fisher tests as appropriate. The 
Kolmogorov–Smirnov test was used to assess the normal 
distribution of quantitative variables. Quantitative and 
normally distributed variables were compared using 
unpaired Student’s t-test and values were expressed as 
mean ± s.d.
Statistical significance was set at P < 0.05. Stepwise 
forward binomial logistic regression analysis was used 
to isolate the independent predicting factors for supra-
aortic and basal ganglia calcifications. Propensity Score 
Matching was used to select a minimum of two controls 
for case. Statistical analyses were carried out using SPSS 
IBM Statistics v.22.0.
Results
From a total of 46 patients diagnosed with permanent 
hypoparathyroidism, 29 agreed to be included in the study 
and underwent a brain CT scan (Fig. 1). All but one were 
females (23). Mean age was 62 ± 17 years. Thyroidectomy 
had been performed for benign goiter in 20 (69%) patients 
and for thyroid cancer in 9 (31%) patients. The mean 
length of follow-up was 9.2 ± 7 years.
Control brain CT scans were obtained from 501 
patients who attended the emergency department for a 
variety of reasons (Fig. 1). Around half of the controls 
were male patients with a mean age of 66 ± 21 years. 
Age and risk factors for BGC and carotid calcifications 
such as diabetes, hypertension, smoking and dyslipidemia 
were similarly distributed in both groups. Male gender 
was less common among the cases. Overall visceral 
calcifications (including both, carotid and BGC), were 
almost seven times more prevalent in the case group. The 
prevalence of carotid calcification was four-fold in the 
case group. BGC was located mainly in globus pallidus and 
tended to be bilateral in both, cases and controls (Table 1). 
Figures 2, 3 and 4 show CT scan imagine of basal ganglia 
and vascular calcifications. Patients with permanent 
hypoparathyroidism had a 20 times higher prevalence of 
BGC (Table 2).
After propensity score matching of the 28 the 
female patients, 68 controls were matched for age and 
presence of cardiovascular factors (Table 3). Cases showed 
almost a four-fold prevalence of BGC, whereas that of 
carotid calcifications was similar between female cases 
and controls.
In multivariate analysis of both cohorts (530 
patients), gender, age, permanent hypoparathyroidism, 
smoking, hypertension, dyslipidemia and diabetes 
were coded as dichotomous variables. The binomial 
logistic regression model (Table 4) isolated permanent 
Table 1 Description of basal ganglia calcifications in five controls and six cases.
Patient Case/control Gender Age Location Side Measurements (mm) (AP/LL/CC) 
FUF Control M 53 Globus pallidus Bilateral 7*7*8 (right) 6*2*3(left)
MEWV Control F 77 Globus pallidus Bilateral 3*1*4 (right) 5*1*5(left)
ABP Control F 80 Globus pallidus Bilateral 7*4*8 (right) 8*6*7(left)
JME Control F 80 Globus pallidus Bilateral 10*5*10 (right) 14*5*9 (left)
EAC Control F 51 Globus pallidus Bilateral 8*5*8(right) 11*4*8(left)
Lenticular nucleus 10*2*5 (right) 6*2*3 (left)
Thalamus 8*7*8 (right) 9*6*9 (left)
Caudate nucleus 18*6*16 (right) 11*6*13 (left)
SSC Case F 43 Globus pallidus Left 1*1*8x
MBM Case F 86 Globus pallidus Right 1*1*3
JLM Case F 70 Globus pallidus Right 1*1*4
DPJ Case F 68 Globus pallidus Bilateral 9*6*7 (right) 8*4*8 (left)
CGV Case F 81 Globus pallidus Left 2*1*7
AMG Case F 68 Globus pallidus Bilateral 7*3*8 (right) 8*5*9 (left)
AP, anteroposterior; CC, caudocranial; LL, latero-lateral.
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hypoparathyroidism, diabetes and dyslipidemia as 
independent predictors of overall visceral and carotid 
calcifications; for the latter, hypertension and smoking 
were also predictive factors. Only hypoparathyroidism 
and to a lesser extent, smoking habit were independent 
factors for BGC.
An independent analysis was performed to compare 
those patients with permanent hypoparathyroidism who 
developed (n = 10) or did not develop (n = 19) calcifications 
(3 of them had both carotid and BG calcifications). No 
association could be identified between and the absence vs 
presence of BGC and BMI (29.9 vs 28.6 kg/m2, P = 0.633), 
age (50.3 vs 57.4 years, P = 0.372), duration of disease (10 
vs 12 years, P = 0.441) or phosphate (4.32 vs 4.24 mg/dL, 
P = 0.841) and creatinine serum levels (0.78 vs 1.13 mg/dL, 
P = 0.351). Whether PTH was undetectable (4.3% vs 20%) 
or low but detectable (95.7% vs 80%), did not have an 
impact on the prevalence of BGC (P = 0.362), probably due 
to small sample size. Episodes of hypercalcemia (35.3% 
vs 40%, P = 1) or hypocalcemia (38.9% vs 10%, P = 0.194) 
did not correlate with BGC. Additionally, there was no 
relation with the type of active vitamin D drugs they 
were receiving (calcitriol (35% vs 40%); and calcifediol 
(65% vs 60%), P = 1). Patients with BGC was receiving 
significantly higher doses of daily calcium (2.6 vs 1.4 g, 
P = 0.030). All patients with BGC was receiving vitamin D 
analogues, whereas only 56.3% of patients without BGC 
did (P = 0.123).
Discussion
Few authors have investigated the long-term clinical 
implications of hypoparathyroidism and even fewer 
have assessed the prevalence of visceral calcifications. 
To our knowledge, the present study is the only one 
comparing the prevalence of BGC between patients 
with postoperative permanent hypoparathyroidism and 
the general population and specifically assessing carotid 
calcifications. The close patient monitoring carried out at 
our Unit differs from the previous publications (2, 8, 9), 
whose data were mostly collected from national registries.
Cross-sectional brain imaging was available in 60% 
of our post-surgical hypoparathyroid patients showing a 
prevalence of BGC of 24%. This is lower than the 50–73% 
reported by other authors. Etiology and duration of disease 
may be the main reason. Goswamy et al. assessed patients 
with idiopathic hypoparathyroidism and in the study 
done by Mitchell et al. a mix of idiopathic, autoimmune 
and post-surgical hypoparathyroidism was included 
and CT scan was only available for 26% of the cohort. 
Nevertheless, other previous cohort studies observed basal 
ganglia calcifications in 12–36% (24, 25). In neither of 
these studies were patients routinely screened for BGC.
Our analysis revealed that patients with post-surgical 
hypoparathyroidism had a four-fold risk for BGC when 
compared with a matched population. Unlike a recent 
cohort-study of acute ischemic stroke patients (13), female 
gender, hypertension, diabetes, hyperlipidemia and older 
age were not associated with BGC.
Some authors have suggested that BGC could be 
associated with the duration of illness (26). In our cohort, 
however, there was no correlation between duration of 
permanent hypoparathyroidism and the development of 
calcifications.
In the present study, carotid calcifications were 
five times more prevalent in patients with permanent 
hypoparathyroidism, than in the control group. 
Figure 2
CT scan imaging of a hypoparathyroid 68-year-old female patient with 
bilateral globus pallidus (A) and dentate nuclei of cerebellum (B) 
calcifications.
Figure 3
CT scan imaging of a 51-year-old female control with bilateral 
calcifications of globus pallidus, lenticular nucleus, thalamus and  
caudate nucleus.
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After matching, however, this difference disappeared. 
The relatively small sample precludes any final conclusion.
The Rotterdam study (16) assessed vascular 
calcifications in 1003 patients and found that 
hypertension, hypercholesterolemia and diabetes were 
significant or near significant risk factors for carotid, aortic 
arch and coronary calcifications and age and current 
smoking were the strongest independent risk factors. In 
the multivariate-adjusted model, current smoking was 
associated with carotid calcification both in women and 
in men. All these risk factors were similar between cases 
and controls in our study. Consistently, binomial logistic 
regression isolated diabetes, dyslipidemia, hypertension 
and current smoking as predictors for carotid calcifications, 
being permanent hypoparathyroidism the most powerful 
predictor. On the contrary, age was not associated with 
carotid calcifications.
A case–control study from India assessing thirty patients 
with sporadic idiopathic hypoparathyroidism found 
thicker ultrasound measured intima-media in carotid, 
aortic and renal arteries when compared with healthy 
subjects. In these patients, serum calcium, iPTH levels 
were low, whereas serum phosphate levels significantly 
higher. No significant correlation was observed, however, 
between biochemical and intima-media thickness or other 
cardiovascular risk factors (27). The authors concluded 
that vascular risk was increased in patients with sporadic 
idiopathic hypoparathyroidism (28).
Carotid artery calcifications, particularly those close 
to carotid bifurcation, may result in important vascular 
obstruction causing stroke. Calcified atheroma plaques in 
carotid arteries may represent an independent marker for 
ischemic symptoms (29, 30, 31).
Underberg et al. analyzed the occurrence of ischemic 
heart disease, stroke and heart failure and concluded that 
Figure 4
CT scan imaging of a hypoparathyroid 90 years 
old female patient with calcification in (A) right 
subclavia artery (arrow) and surgical clips (*), and 
(B) left carotid bifurcation (arrow) after 
thyroidectomy for benign goiter.
Table 2 Demographic variables, cardiovascular risk factors 
and prevalence of basal ganglia and carotid calcifications of  
29 patients with postoperative permanent 
hypoparathyroidism (cases) and 501 controls.
Cases (n = 29) Controls (n = 501) P
Age (years)a 62 ± 17 (26–95) 66 ± 21 (4–100) 0.352
Gender <0.001b
 Male 1 (3.4) 264 (52.7)
 Female 28 (96.6) 237 (47.3)
Diabetes 5 (17.2) 129 (25.7) 0.383
Hypertension 13 (44.8) 276 (55.1) 0.281
Dyslipidaemia 11 (37.9) 165 (32.9) 0.579
Smoker status 0.695
 Non-smoker 22 (75.9) 411 (82)
 Smoker 4 (13.8) 54 (10.8)
 Ex-smoker 3 (10.3) 36 (7.2)
Carotid 
calcifications
7 (24.1) 26 (5.2) <0.001
BG calcifications 6 (20.7) 5 (1) <0.001
Values in parentheses are percentages unless indicated otherwise.
aValues are mean ± s.d. (range); bFisher’s exact test.
BG, basal ganglia.
Table 3 Prevalence of basal ganglia and carotid calcifications 
in female patients after propensity score matching by age, 
presence of diabetes, hypertension, dyslipidemia and smoke 
status to mate cases–controls.
Cases (n = 28) Controls (n = 68) P
Age (years) 62.3 ± 17 63.5 ± 21 0.739
Diabetes 4 (14.3) 23 (33.8) 0.079a
Hypertension 12 (42.8) 33 (48.5) 0.613
Dyslipidaemia 10 (35.7) 28 (41.2) 0.619
Smoker 3 (10.7) 5 (7.4) 0.892a
Carotid calcifications 6 (21.4) 9 (13.2) 0.315
BG calcifications 6 (21.4) 4 (5.9) 0.031a
Values in parentheses are percentages. Quantitative values are expressed 
in mean ± s.d.
aFisher’s exact test.
BG, basal ganglia.
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cardiovascular risk was not increased in post-surgical 
hypoparathyroidism (8). In this study, however, the 
prevalence of carotid calcifications was not assessed, so 
their possible association with cardiovascular could not 
be assessed.
Whereas less than half of the controls were female, 
more than 96% of the cases were of female gender, 
consistent with the usual proportion in thyroid disease 
requiring surgery. To minimize this confounding factor, 
a propensity score matching was carried out excluding 
male patients and selecting at least two similar female 
controls for every patient matching for age, diabetes, 
hypertension, dyslipidemia and smoking status. Thus, in 
female patients, the prevalence of carotid calcifications 
was similar in cases and controls, whereas the prevalence 
of BGC was four-fold in patients.
A potential limitation of our study is that controls 
were not representative of general populations and there 
may be a selection bias since almost 25% underwent a 
CT-scan because a stroke was suspected. And yet, the 
control group had significantly less prevalence of carotid 
calcifications. Another limitation was that data of BMI was 
not available for the control group and it has been shown 
to be a predictive factor for basal ganglia calcifications. 
We did analyze, however, the influence of BMI on the 
prevalence of BGC and carotid calcifications in the cases 
and could not find an association.
BGC is briefly mentioned in the current European 
Guidelines on the management of permanent 
hypoparathyroidism that focus primarily on 
nephrolithiasis and nephrocalcinosis and just state 
that ‘an increase in brain calcifications has only been 
documented in non-surgical hypoparathyroidism’. They 
do not make a specific recommendation on monitoring 
neither for BGC nor for vascular calcifications (7). 
Although the clinical implications of BGC is unclear 
(and need to be addressed in future studies), the present 
findings indicate that patients should be probably 
monitored for this.
In conclusion, our study shows a higher prevalence of 
BGC and, probably, of carotid calcifications among post-
surgical permanent hypoparathyroid patients in comparison 
with a control population. Further studies should be 
designed to assess the clinical meaning of these findings that 
may have an impact on patients’s quality of life.
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